meloxicam stada 7.5 mg comprimidos efg
laboratorio stada s.l. - meloxicam - comprimido - 7,5 mg - meloxicam 7,5 mg - meloxicam
parocin 15 mg comprimidos
boehringer ingelheim espana s.a. - meloxicam - comprimido - 15 mg - meloxicam 15 mg - meloxicam
uticox 15 mg supositorios
laboratorios yer, s.a. - meloxicam - excipientes: - productos antiinflamatorios y antirreumÁticos no esteroideos - oxicams - meloxicam
immufalk 100 mg comprimidos recubiertos con pelicula
dr. falk pharma gmbh - azatioprina - comprimido recubierto con pelÍcula - 100 mg - azatioprina 100 mg - azatioprina
immufalk 75 mg comprimidos recubiertos con pelicula
dr. falk pharma gmbh - azatioprina - comprimido recubierto con pelÍcula - 75 mg - azatioprina 75 mg - azatioprina
jayempi
nova laboratories ireland limited - azathioprine - rechazo del injerto - inmunosupresores - jayempi is indicated in combination with other immunosuppressive agents for the prophylaxis of transplant rejection in patients receiving allogenic kidney, liver, heart, lung or pancreas transplants. azathioprine is indicated in immunosuppressive regimens as an adjunct to immunosuppressive agents that form the mainstay of treatment (basis immunosuppression). jayempi is used as an immunosuppressant antimetabolite either alone or, more commonly, in combination with other agents (usually corticosteroids) and/ or procedures which influence the immune response. jayempi is indicated in patients who are intolerant to glucocorticosteroids or if the therapeutic response is inadequate despite treatment with high doses of glucocorticosteroids, in the following diseases:severe active rheumatoid arthritis (chronic polyarthritis) that cannot be kept under control by less toxic agents (disease-modifying anti-rheumatic -medicinal products – dmards)auto-immune hepatitis systemic lupus erythematosusdermatomyositispolyarteritis nodosapemphigus vulgaris and bullous pemphigoidbehçet’s diseaserefractory auto-immune haemolytic anaemia, caused by warm igg antibodieschronic refractory idiopathic thrombocytopenic purpurajayempi is used for the treatment of moderately severe to severe forms of chronic inflammatory bowel disease (ibd) (crohn’s disease or ulcerative colitis) in patients in whom glucocorticosteroid therapy is necessary, but where glucocorticosteroids are not tolerated, or in whom the disease is untreatable with other common means of first choice. it is also indicated in adult patients in relapsing multiple sclerosis, if an immunomodulatory therapy is indicated but beta interferon therapy is not possible, or a stable course has been achieved with previous treatment with azathioprine. 3jayempi is indicated for the treatment of generalised myasthenia gravis. depending on the severity of the disease, jayempi should be given in combination with glucocorticosteroids because of slow onset of action at the beginning of treatment and the glucocorticosteroid dose should be gradually reduced after several months of treatment.
lidbree 42 mg/ml gel intrauterino
gedeon richter plc. - lidocaina - gel intrauterino - 42 mg/ml - lidocaina 42 mg - lidocaína
bimacure 500 mg suspension intrauterina para bovino
bimeda animal health limited - cefapirina benzatina - suspensiÓn intrauterina - cefapirina benzatina 500 mg - cefapirina - vacas
paldolor® extra forte nf 500mg tableta
hersil s.a.c laboratorios industriales farmaceuticos - laboratorio - diclofenaco; paracetamol; - tableta - por tableta - - paracetamol
choriomon 5000 ui polvo y disolvente para solucion inyectable
eurofarma peru s.a.c. - droguerÍa - gonadotropina coriónica humana (hcg) - polvo y disolvente para solucion inyectable - 5000ui - por vial - - gonadotrofina coriónica